The efficacy and safety of glofitamab combined with polatuzumab vedotin in the treatment of 9 cases of relapsed/refractory diffuse large B-cell lymphoma after failing CAR-T cell therapy

Columvi (glofitamab-gxbm) - Roche

Polivy (polatuzumab vedotin-piiq) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42706179

H R Lyu; H Zhang; M F Zhao; X Xiao; X Y He

Sep 8, 2026